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Abstract: Cumulative risk assessment has been proposed as an approach to evaluate the 
health risks associated with simultaneous exposure to multiple chemical and non-chemical 
stressors. Physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models 
can allow for the inclusion and evaluation of multiple stressors, including non-chemical 
stressors, but studies have not leveraged PBPK/PD models to jointly consider these 
disparate exposures in a cumulative risk context. In this study, we focused on exposures to 
organophosphate (OP) pesticides for children in urban low-income environments, where 
these children would be simultaneously exposed to other pesticides (including pyrethroids) 
and non-chemical stressors that may modify the effects of these exposures (including diet). 
We developed a methodological framework to evaluate chemical and non-chemical 
stressor impacts on OPs, utilizing an existing PBPK/PD model for chlorpyrifos. We 
evaluated population-specific stressors that would influence OP doses or acetylcholinesterase 
(AChE) inhibition, the relevant PD outcome. We incorporated the impact of simultaneous 
exposure to pyrethroids and dietary factors on OP dose through the compartments of 
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metabolism and PD outcome within the PBPK model, and simulated combinations of 
stressors across multiple exposure ranges and potential body weights. Our analyses 
demonstrated that both chemical and non-chemical stressors can influence the health 
implications of OP exposures, with up to 5-fold variability in AChE inhibition across 
combinations of stressor values for a given OP dose. We demonstrate an approach for 
modeling OP risks in the presence of other population-specific environmental stressors, 
providing insight about co-exposures and variability factors that most impact OP health 
risks and contribute to children’s cumulative health risk from pesticides. More generally, 
this framework can be used to inform cumulative risk assessment for any compound 
impacted by chemical and non-chemical stressors through metabolism or PD outcomes. 
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1. Introduction  
Cumulative risk assessment has recently emerged as an area of interest among regulators as well as 
stakeholders concerned about environmental justice [1–3]. The U.S. EPA’s Framework for Cumulative 
Risk Assessment defines cumulative risk formally as “the combined risks from aggregate exposures to 
multiple agents or stressors” [4]. Of note, the EPA considers cumulative risk assessment to include 
both chemical and non-chemical stressors, the latter of which may potentially include (but not be 
limited to) low income, low community property values, limited access to health care, psychosocial 
stress, and other stressors not commonly within the purview of EPA decision-making. 
Despite the inclusion of non-chemical stressors in the definition of cumulative risk, cumulative risk 
assessments to date have typically ignored those stressors [5]. This is largely because toxicological 
studies do not have the capacity to consider most non-chemical stressors, as well as because of the 
limited availability of epidemiological evidence. However, a recent report evaluating risk assessment 
methods [6] reinforced the priority that needs to be placed on evaluating risks from multiple stressors 
simultaneously, with a particular emphasis on identifying how multiple chemical and non-chemical 
stressors impact individual and population health.  
Conceptual frameworks have been developed for cumulative risk assessments that capture chemical 
and non-chemical stressors [7], but such frameworks have not been linked with the methods 
commonly used for modeling exposures and health outcomes within risk assessment. In particular, 
there are limited methods to date to evaluate the impacts of chemical and non-chemical stressors on the 
internal doses or resulting health effects of an environmental toxicant. 
Pesticides have been at the forefront of the cumulative risk discussion, based on the Food Quality 
Protection Act of 1996, which specifically mandates that pesticides with a common mechanism of 
action be evaluated for their cumulative health risks [8]. Cumulative risk assessments have been 
conducted for organophosphate (OP) pesticides, which as a group have a common primary mechanism 
of action, acetylcholinesterase (AChE) inhibition [9–11]. These assessments have included multiple 
OPs and exposure pathways, capturing one key dimension of modeling neurocognitive effects, but did 
not consider other potential stressors with similar mechanisms or that would impact the metabolism of Int. J. Environ. Res. Public Health 2012, 9 1973 
 
 
OPs or their mechanism of action. Non-chemical physiological and psychosocial stresses can have 
indirect biochemical and neurological effects similar to those of the OPs. This issue may be 
particularly salient for children in low-income urban environments, who have been shown to have 
simultaneous exposure to multiple pesticides [12] and who exhibit high levels of three important   
non-chemical stressors: obesity, inadequate nutrition, and psychosocial stress. A recent study in urban 
public housing [13] found 56% of children to be overweight, with 41% of caregivers not allowing their 
children to play outside due to neighborhood violence and 84% of caregivers of children under age 8 
reporting fear of violence. However, no studies have formally considered how these stressors could 
influence the health risks associated with OP exposures. 
Within this study, our aim was to develop a theoretical risk framework for evaluating cumulative 
risk to OPs in the presence of other chemical and non-chemical stressors, using physiologically-based 
pharmacokinetic/pharmacodynamic (PBPK/PD) models to quantify the impacts of these stressors on 
OP internal dose and AChE inhibition. We developed methods for incorporating the biochemical 
effects of a subset of common non-chemical stressors affecting metabolism and the pharmacodynamic 
outcome. We simulated internal doses and AChE inhibition for children characteristic of an urban  
low-income environment and discuss the relative impacts of multiple stressors on OP doses and factors 
that contribute most to increased risk of AChE inhibition amongst this population. The theoretical 
framework developed here, with OPs as an illustrative example, can be utilized for any chemical that 
may be impacted by stressors through metabolism or mechanism of action, and provides a first effort 
at a methodological framework to quantify the cumulative impact of chemical and non-chemical 
stressors on an individual’s health risk. 
2. Methods 
2.1. Cumulative Risk Framework Development 
We developed a framework for cumulative risk assessment that relies on an understanding of the 
physiologic processes that lead to a critical health outcome, such as AChE inhibition. Figure 1 shows a 
diagram of our conceptual framework using an OP, chlorpyrifos (CPF), and exposure and stressors for 
urban low-income children as an example (described in detail in sections to follow). In this framework 
approach, biochemicals, metabolic processes and target tissues are identified that would be affected by 
exposure to OPs or stressors, including the general pool of enzyme proteins, enzymes specific to OP 
metabolism, and the pool of AChE enzyme, particularly in the brain. Specific stressors are identified 
that have direct effects on AChE (e.g., CPF-oxon metabolite) and that affect the general pool of 
enzyme proteins available for physiological needs, including AChE (e.g., diet).  
The elements of the framework are integrated by a PBPK/PD model to describe the internal 
relationships of tissue concentrations, enzymatic processes and the quantitative effects of chemical and 
non-chemical stressors, and quantification of a health relevant outcome, in this case changes in AChE 
inhibition. Thus, within the present study, framework development involved systematically evaluating 
which stressors were both relevant for our urban low-income population of children and could 
influence PBPK/PD model parameters. Specifically, we sought out evidence about stressors that would 
influence general physiological factors, or that would impact the metabolism of OPs and the percent Int. J. Environ. Res. Public Health 2012, 9 1974 
 
 
AChE inhibition, both model components that would directly impact CPF-oxon doses or the health 
outcome. We then used the developed framework to infuse changes that would reflect CPF PBPK/PD 
model parameter impacts due to stressors relevant for our population with this example. 
Figure 1. Diagram of risk framework using PBPK/PD model application for OPs with 
chemical and non-chemical stressors (Parentheses depict specifics for this example). 
 
 
Within this study, though OP doses vary with age, gender, and other characteristics, we simulated 
sets of individuals with a fixed set of characteristics in order to isolate the impacts of the additional 
stressors of interest. We modeled 2-year-old females with a median height, noting that 2-year-olds will 
have greater enzyme levels than younger children. We performed our stressor simulations using a 
modified version of the CPF PBPK/PD model, previously developed by Timchalk et al. [14].  
2.2. Evaluation of Additional Chemical Stressors 
Both pyrethroids and OP pesticides were found frequently in the homes of children in the   
low-income population we use to generate our study population, with many homes having five or more 
pesticides across both groups [12]. OPs and pyrethroids are metabolized by similar CYP enzymes, 
with pyrethroids also being primarily detoxified by carboxylesterase enzymes (which are almost 
irreversibly bound to OPs). Significant associations were found between CPF metabolites and 
CYP3A4/5, CYP2C8, CYP2C19 and CYP1A2 [15]. Human CYP450 isoforms that showed activity 
toward multiple pyrethroids were CYP2C8, CYP2C9, CYP2C19, and CYP3A4 [16], indicating that an 
overlapping profile of metabolizing enzymes exists for the two groups. While OPs impact pyrethroid 
metabolism significantly, pyrethroids have been found to be weak inhibitors of OPs [17]. However, the Int. J. Environ. Res. Public Health 2012, 9 1975 
 
 
combined exposure and shared metabolic enzymes indicate that pyrethroids also have the potential to 
have an effect on OP dosimetry. Other chemical stressors may have been present in the residential 
environment that could impact CPF or CPF-oxon doses, but they were unknown or not characterized 
for this population. No other chemicals were present to our knowledge that directly impacted AChE 
inhibition (e.g., carbamates).  
2.3. Evaluation of Non-Chemical Stressors 
Within our literature review, we focused on non-chemical stressors that were relevant to low-income 
urban children, which would potentially influence the effects of OP exposure, and had sufficient data 
available to indicate how the PBPK/PD model should be modified. While there is insufficient 
information to understand the majority of the possible interactions that could occur between chemical 
and non-chemical stressors, we sought to capture how selected common non-chemical stressors might 
modify general physiological parameters (e.g., weight), metabolic parameters (e.g., Vmax, maximum 
velocity of reaction), and AChE inhibition (e.g., through estimating underlying AChE levels).  
A host of potential stressors relevant to urban or low-income children have been reported. Given 
our emphases listed above, we found the most consistent and relevant evidence to support psychosocial 
stress (often related to exposure to community violence) and diet as non-chemical stressors for this 
population. Stress and diet were thus further evaluated for their potential impacts on physiology,   
OP metabolism, and AChE inhibition.  
First considering psychosocial stress, studies confirmed its importance for a variety of health 
outcomes as well as consistently elevated rates in low-income urban populations [18,19]. Exposure to 
community violence represented a particular stressor within these communities [20–22]. Severe acute 
or chronic stress has been shown to impact important metabolic pathways, particularly causing 
hormonal changes that can lead to increased susceptibility to environmental toxicants [23,24]. 
However, evaluations of direct impacts of acute and repeated stress in animals prior to CPF exposure 
showed no impact on AChE inhibition [25]. Thus, although psychosocial stress is clearly important for 
numerous outcomes and likely impacts these exposures in some capacity, quantitative evidence did not 
presently exist to suggest a direct impact on either OP metabolism or AChE inhibition, and data 
regarding general impacts were not available that could be incorporated in this assessment.  
For diet, obesity rates are highest among low-income, minority, urban children [26], with a recent 
study in urban public housing [13] finding 56% of children to be overweight. Irigoyen et al. also found 
obesity percentages for urban low-income children ages 1–5 to be 7.5% (age 1), 20% (age 2), and 30% 
(ages 3–5) [26]. Increased weight leads to increased fat volumes, which could lead to prolonged 
exposure to OPs for obese children due to the high fat partition coefficients for OPs. Furthermore,  
low-income children were more likely to have a diet comprised of lower protein and a higher 
percentage of fat and sugars, with mean percentage of calories from carbohydrates, protein, and fat of 
57%, 13%, and 32%, respectively, with between 69–94% not meeting the minimum number of 
servings of fruit, vegetables, grain, meat/poultry, and dairy [27]. These dietary impacts can lead to 
changes in important enzyme levels and metabolism of environmental toxicants [28]. Long-term high 
sugar, high fat diets have been directly associated with decreased levels of AChE activity [29], with 
low protein diets more generally associated with lower enzyme production levels [30,31]. Decreased Int. J. Environ. Res. Public Health 2012, 9 1976 
 
 
AChE activity due to diet could add to the percent inhibition occurring due to OP exposure. Low 
enzyme production could lead to decreased CPF-oxon production, but also decreases in the PON1 
enzymes needed to detoxify the CPF-oxon metabolite. Thus, the available evidence supported diet as 
having a direct impact on both metabolism and AChE inhibition, with obesity additionally influencing 
the PBPK/PD model structure and outputs.  
2.4. Simulation Approach 
As a result of our review of stressors for urban low-income children, enzymatic impacts from 
concurrent pyrethroid exposure and physiological changes from dietary factors were included, with the 
resulting framework illustrated in Figure 1. The effects of pyrethroid exposure were incorporated through 
the metabolism compartment, with modifications in the Vmax (maximum velocity of reaction) parameter 
values for the CYP and PON1 metabolizing enzymes. Dietary factor impacts were incorporated in 
several ways. First, elevated body mass index was incorporated through overall body weight and tissue 
volume modifications, in order to evaluate whether body weight, and in particular fat volume, 
influenced our findings. Dietary stressor impacts were also incorporated through the compartments of 
metabolism and the pharmacodynamic outcome. A low-protein diet reduces the formation rate of 
enzyme protein, which proportionally reduces Vmax, increasing sensitivity to OP exposure. Lower protein 
could also reduce metabolic formation of toxic OP metabolites. The pharmacodynamic outcome was 
incorporated through decreased AChE levels in the body due to a high fat/high sugar diet. 
In all cases, data did not allow for precise estimation of the effect of the chemical or non-chemical 
stressor, but we developed approximations to capture the upper bound potential impacts of these 
stressors. Distributions of data for these stressors would be optimal to include in order to fully consider 
variability due to these stressors. However, incorporation of bounding estimates in the absence of 
available distributional data allows for an initial characterization of the likely importance of these 
stressors from a health relevant standpoint and demonstration of proof of concept of our theoretical 
framework. For alterations in the metabolism compartment, we assumed a theoretical value of 50% 
reduction in Vmax values as a result of co-exposure to pyrethroids and decreased overall enzyme levels 
with a low-protein diet. Although exact effects of diet on metabolism have not been reported, studies 
have consistently shown that diet has a negative impact on overall enzyme levels [32–34]. Furthermore, 
a 50% reduction in Vmax is plausible given ranges of Vmax values that capture polymorphic enzymes 
and interindividual variability. Foxenberg et al. reported Vmax values that spanned between 2–12 fold 
depending on the enzyme group, with CYP enzymes having a 4-fold Vmax range for the 2-year-old age 
group (e.g., from half the standard reported value to 2× the reported value) [35]. 
Effects of body mass index were simulated by incorporating a range of plausible values, determined 
from the Center for Disease Control and Prevention’s clinical growth charts [36]. We focused on 
females age 1–2 (12–24 months) and considered children of median weight at 18 months (10.9 kg) as the 
comparison group. A lower bound weight was taken from the 5th percentile at 12.5 months (8.13 kg) and 
an upper bound weight was taken from the 95th percentile at 23.5 months (14.5 kg). In all cases, we 
considered a median height of 79.8 cm to allow for a range of body mass index values. This method 
created body mass index values well below the 5th and well above the 95th percentile, to examine  
the range of impact for this framework exercise. A long-term high fat/high sugar diet caused between  Int. J. Environ. Res. Public Health 2012, 9 1977 
 
 
20–40% decreases in AChE activity for females in animal studies [29]. This potential decrease could 
reduce the amount of AChE available to break down acetylcholine, in combination with the reduction 
occurring through OP exposure. In order to quantify how much of an impact the diet stressor could 
have on AChE inhibition, we assumed the maximum reported decrease of 40% in AChE binding sites 
during the simulations. 
With these parameter modifications in place, we ran a series of sensitivity analyses across selected 
CPF input exposure values from previous exposure modeling work. This study simulated dermal and 
ingestion exposures for young children from dust concentration measurements in their urban low-income 
residences [37,38] (median, 95th percentile, and maximum). We combine these estimates for 2-year-
old children with varying combinations of stressors (i.e., across weight values, with the pyrethroid 
chemical stressor, with the low protein, high fat and sugar diet stressor, and with both stressors). CPF 
doses were simulated for 21 days of exposure, in order for AChE inhibition to reach steady state.  
We used the models to estimate the theoretical CPF-oxon area-under-the-curve (AUC) in the brain 
tissues at day 21, along with the maximum value percent AChE inhibition at steady state associated 
with CPF-oxon concentrations. Maximum value percent inhibition at day 21 is presented here to 
represent the upper bound value that could occur in each sensitivity analysis. In each case, we compare 
children with additional chemical and non-chemical stressors with the child within their exposure 
range with normal parameters as a baseline. We determined which factor or combination of factors 
most significantly influence percent AChE inhibition in the brain.  
3. Results 
First considering a child at median exposure, the CPF-oxon brain AUC values and corresponding 
maximum percent AChE inhibition in the brain varied significantly across stressor simulations, with 
percent AChE inhibition varying from 14% less to 5 times more than seen for the baseline child  
(Table 1). The highest percent inhibition values corresponded with children with the 95th percentile 
weight and both the pyrethroid and diet stressors (Table 1). While the combination of stressors yielded 
the greatest effect, all stressors individually contributed to increases in percent AChE inhibition.   
For example, the increased body mass index contributed to a roughly proportionate increase in percent 
AChE inhibition. The reduced Vmax approximately doubled AChE inhibition given normal AChE 
binding sites, but displayed a less than proportionate increase given decreased binding sites. The AChE 
binding site decreases from diet contributed an approximate factor of 2–4 increase in inhibition across 
other parameter values. At higher levels of exposure, the patterns are similar, though with some 
modest differences in the individual and joint contributions of factors (Table 1). As expected, percent 
AChE inhibition increased with exposure level across simulations. In each case, only the child with 
low body weight and normal levels of Vmax and AChE binding sites demonstrated lower percent AChE 
inhibition than the baseline child, with approximate 20% reductions. Additionally, in each case, the 
child with high body weight and both the pyrethroid and diet stressors exhibited inhibition 
approximately 2.5 times higher than the level for the baseline child (a lower ratio than seen for the 
children at median exposure). Each of the stressors made a significant contribution, though at the 
higher exposure levels, decreased binding sites had a lower relative influence than at the lower 
exposure levels, suggesting that enzyme saturation may occur at the higher exposure levels. At the Int. J. Environ. Res. Public Health 2012, 9 1978 
 
 
highest exposure level and combination of stressors, the percent AChE inhibition reached a maximum 
value of 0.148%, substantially greater than for the child at median exposure without additional 
stressors. 
Table 1. Percent AChE inhibition changes in the brain after 21 day CPF exposure with 
inclusion of a chemical and non-chemical stressor. 
Exposure  
(μg/kg/day) 
Weight Vmax 
AChE 
binding 
sites 
AUC  
CPF-oxon 
brain 
(μg/kg/day) 
% AChE 
inhibition 
brain 
(Maximum) 
Ratio - % inhibition 
in simulated  
child/ % inhibition 
in comparison child 
Median  
(0.075 derm, 0.003 ing) 
median 
(10.9 kg) 
normal *  normal  0.056  0.00028  Median child 
  5% (8.13 kg)  normal  normal  0.060  0.00024  0.86 
 95%  (14.5  kg)  normal  normal  0.050  0.00036  1.29 
 median    ↓ 50%  normal  0.111  0.00057  2.04 
 5%  ↓ 50%  normal  0.119  0.00048  1.71 
 95%  ↓ 50%  normal  0.100  0.00069  2.46 
 median    normal  ↓ 40%  0.056  0.00100  3.57 
 5%  normal  ↓ 40%  0.060  0.00090  3.21 
 95%  normal  ↓ 40%  0.050  0.0011  3.93 
 median  ↓ 50%  ↓ 40%  0.111  0.0013  4.64 
 5%  ↓ 50%  ↓ 40%  0.119  0.0012  4.29 
 95%  ↓ 50%  ↓ 40%  0.100  0.0014  5.00 
95th percentile  
(0.876 derm, 0.417 ing) 
median  normal  normal  0.631  0.0034  95th % child 
 5%  normal  normal  0.618  0.0027  0.79 
 95%  normal  normal  0.615  0.0041  1.21 
 median  ↓ 50%  normal  1.26  0.0068  2.00 
 5%  ↓ 50%  normal  1.23  0.0055  1.62 
 95%  ↓ 50%  normal  1.23  0.0081  2.38 
 median    normal  ↓ 40%  0.631  0.0046  1.35 
 5%  normal  ↓ 40%  0.618  0.0038  1.12 
 95%  normal  ↓ 40%  0.615  0.0055  1.62 
 median  ↓ 50%  ↓ 40%  1.26  0.0074  2.18 
 5%  ↓ 50%  ↓ 40%  1.23  0.0062  1.82 
 95%  ↓ 50%  ↓ 40%  1.23  0.0088  2.59 
Maximum  
(15.9 derm, 0.820 ing) 
median normal  normal  10.8 0.0615  Max  child 
 5%  normal  normal  9.69  0.0501  0.81 
 95%  normal  normal  9.62  0.0738  1.20 
 median  ↓ 50%  normal  21.5  0.1230  2.00 
 5%  ↓ 50%  normal  19.3  0.1000  1.63 
 95%  ↓ 50%  normal  19.2  0.1470  2.39 
 median    normal  ↓ 40%  10.8  0.0720  1.17 
 5%  normal  ↓ 40%  9.69  0.0580  0.94 
 95%  normal  ↓ 40%  9.62  0.0880  1.43 
 median  ↓ 50%  ↓ 40%  21.5  0.1230  2.00 
 5%  ↓ 50%  ↓ 40%  19.3  0.1000  1.63 
   95%  ↓ 50%  ↓ 40%  19.2  0.1480  2.41 
* Normal values still scaled by weight, then modified; derm = dermal, ing = ingestion. Int. J. Environ. Res. Public Health 2012, 9 1979 
 
 
4. Discussion and Conclusions 
In this study, we have developed and applied a framework (shown in Figure 1) for using PBPK/PD 
modeling to quantitatively evaluate the impacts of chemical and non-chemical stressors on an 
individual chemical exposure and corresponding potential health impact. Within our simulations, 
focused on CPF exposures, doses and percent AChE inhibition varied considerably (up to a factor of 
five) across stressor factor combinations. Even given the limited information available to estimate 
effects within a PBPK/PD framework, our approach allowed for characterization of relative impacts of 
multiple stressors on OP doses and factors that contribute most to increased risk of AChE inhibition 
amongst this simulated population.  
We concluded in this example that high body mass index and physiological impacts from 
pyrethroid and diet stressors would impact the amount of AChE inhibition associated with CPF 
exposures. This combination of stressors is likely to be present for young children living in an urban 
low-income environment. While variability in exposure inputs would tend to dominate the effects of 
these stressors [37,38], omission of these and other stressors may underestimate the effects of 
pesticides in low-income communities. Some non-linearities were seen at the higher exposure levels 
with the inclusion of the diet stressor, which decreases available AChE levels. In comparison to the 
linear relationship seen with increased percent inhibition as stressors were added to the analyses at the 
median exposure levels, the relationship at the higher exposure levels with the inclusion of diet was 
non-linear, suggesting that enzyme saturation may occur at these exposure levels. Our study suggests 
the importance of a systematic methodology to consider the effects of numerous chemical and non-
chemical stressors within PBPK/PD modeling, as an approach for enhancing cumulative risk 
assessment and providing unbiased health risk estimates.  
There are some clear limitations in our analysis, even given the fact that we presented an intentionally 
stylized example. First, even with the combination of stressors at the highest level of exposure, the 
percent AChE inhibition would seem to indicate limited risk, which would reduce the importance of 
incorporating various stressors. Studies in the literature indicate that >20% inhibition is generally 
considered as a level of concern, as compared with our maximum level of 0.148%, although the 
threshold value may be lower for developing children [9]. In other words, the variability in this   
risk-relevant metric would not likely correspond with detectable variability in risk. However, our 
exposure inputs only included non-dietary routes of exposure, and inclusion of additional routes of 
exposure as well as additional pesticides and non-chemical stressors may lead to more significant 
percent AChE inhibition estimates. More generally, our goal was not to comprehensively determine 
exposures and corresponding health risks, but to suggest a methodology by which non-chemical 
stressors could be introduced into the cumulative risk paradigm, and our methods could be applied in 
many other contexts.  
In addition, the proposed framework may not be applicable in the near term for many compounds, 
given limitations in the number of currently available PBPK/PD models, especially given the desire for 
models with the pharmacodynamic component that allows for evaluation of a health relevant outcome. 
However, this proof of concept application coupled with growing interest in cumulative risk assessment 
may stimulate the development of novel PBPK/PD models with cumulative risk applications in mind, 
or the consideration of how various chemical and non-chemical stressors may influence metabolic Int. J. Environ. Res. Public Health 2012, 9 1980 
 
 
processes or pharmacodynamic outcomes in existing models. This is supported by a recent article by 
Tan et al., which considered approaches for evaluating interactions between multiple chemical stressors 
with PBPK/PD modeling and highlighted the overall utility of computational modeling for   
cumulative risk assessment [39]. Efforts are also ongoing presently to develop a family PBPK model 
for the pyrethroid pesticides, building upon deltamethrin models developed and refined by   
Mirfazaelian  et al. [40] and Godin et al. [41], respectfully, which could potentially allow for 
evaluation of chemical and non-chemical stressor impacts on this widely used pesticide group.   
As mentioned previously, OPs almost irreversibly inhibit the major metabolizing enzymes for 
pyrethroids, carboxylesterases, leading to increased toxicity from the parent compound that could 
extend to human health effects [42]. If OPs were incorporated as a chemical stressor for pyrethroids, 
the impact of OPs on pyrethroid toxicity could be evaluated using this framework, providing great 
insight into the magnitude of health impact changes occurring as a result of their combined exposures.  
An additional limitation stems from the fact that we were limited in available data regarding 
stressors, both for stressors included in this study and those not included, since we could only capture 
stressors with documented impacts on metabolism or that have been previously shown to directly 
impact the pharmacodynamic outcome. Other stressors, including but not limited to psychosocial 
stress, likely impact these physiological systems and outcomes in a manner that may lead to a relevant 
health impact; however, data did not exist at the time of our investigation to adequately understand or 
quantify these impacts in a PBPK/PD modeling framework. Data were also limited regarding the 
stressors that were incorporated. Additional data are necessary in order to utilize representative data 
distributions to capture the full range of variability that may occur due to these stressors.   
An intentionally stylized approach with bounding calculations for stressor data was applied in this 
study, with the aim that the theoretical framework concept derived here could be further validated and 
enhanced as more data becomes available. Propagating uncertainty and variability throughout the 
analysis would allow for refinement of the potential health impact of these stressors and evaluation of 
the sources and magnitude of uncertainty and variability. We recommend additional studies and data 
collection oriented around the effects of these non-chemical stressors on specific PBPK/PD model 
parameters. Future studies should evaluate stressor data variability and uncertainty and report these 
values. More generally, while our inclusion of stressors is clearly not comprehensive, the stressors 
addressed within our application allow us to understand the potential magnitude of impact that a 
stressor of this kind may have on a specific chemical exposure.  
In spite of these limitations, our work offers a new methodological framework within which 
chemical and non-chemical stressors can be jointly considered in the emerging area of cumulative risk 
assessment. The theoretical framework developed here, with OPs as an illustrative example, can be 
utilized for any chemical that may be impacted by stressors through metabolism or mechanism of 
action. This structure can be utilized to evaluate the impacts of multiple chemical and non-chemical 
stressors simultaneously on an individual chemical. This work could also be extrapolated to include 
multiple primary compounds within the same chemical family, or with the same mode of action (e.g., 
multiple OPs). The framework provided herein includes both a systematic approach to evaluate 
potential stressors for inclusion in the assessment as well as quantitative methods to assess the impact 
of included stressors on a health relevant outcome, which can help determine which stressors may be 
important to include from a health-relevant standpoint. Int. J. Environ. Res. Public Health 2012, 9 1981 
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